- Home
- SNN
as 04-18-2025 1:43pm EST
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
| Founded: | 1856 | Country: | United Kingdom |
| Employees: | N/A | City: | N/A |
| Market Cap: | 12.3B | IPO Year: | 1999 |
| Target Price: | $27.00 | AVG Volume (30 days): | 1.2M |
| Analyst Decision: | Hold | Number of Analysts: | 3 |
| Dividend Yield: | Dividend Payout Frequency: | Semi-Annual | |
| EPS: | 0.47 | EPS Growth: | 56.15 |
| 52 Week Low/High: | $23.65 - $31.72 | Next Earning Date: | 02-25-2025 |
| Revenue: | $5,810,000,000 | Revenue Growth: | 4.70% |
| Revenue Growth (this year): | 6.42% | Revenue Growth (next year): | 5.03% |
Latest Smith & Nephew SNATS Inc. News
SNN Breaking Stock News: Dive into SNN Ticker-Specific Updates for Smart Investing
Simply Wall St.
11 days ago
Are Poor Financial Prospects Dragging Down Smith & Nephew plc (LON:SN. Stock?
Insider Monkey
18 days ago
Is Smith & Nephew plc (SNN) the Most Undervalued Healthcare Stock to Buy According to Analysts?
Simply Wall St.
a month ago
Here's Why We're Wary Of Buying Smith & Nephew's (LON:SN.) For Its Upcoming Dividend
Simply Wall St.
a month ago
Smith & Nephew's (LON:SN.) Solid Earnings Are Supported By Other Strong Factors
Simply Wall St.
a month ago
Smith & Nephew Full Year 2024 Earnings: EPS Misses Expectations
GlobeNewswire
a month ago
Smith+Nephew to showcase advanced Orthopaedic Reconstruction technologies for Robotics, Knees, Hips, and Shoulders at AAOS 2025
GlobeNewswire
a month ago
Smith+Nephew to highlight breakthrough Sports Medicine technologies for joint repair at AAOS 2025
GlobeNewswire
a month ago
New report confirms Smith+Nephew’s OXINIUM™ Technology is the best performing bearing surface at 20 years for total hip arthroplasty
Compare SNN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SNN Smith & Nephew SNATS Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.